Management of acute malignant large-bowel obstruction with self-expanding metal stent

Surg Endosc. 2007 Jul;21(7):1101-3. doi: 10.1007/s00464-007-9258-0. Epub 2007 Mar 14.

Abstract

Background: Colorectal stents are being used for palliation and as a "bridge to surgery" in obstructing colorectal carcinoma. The purpose of this study was to review our experience with self-expanding metal stents (SEMS) as the initial interventional approach in the management of acute malignant large bowel obstruction.

Methods: Between February 2002 and May 2006, 67 patients underwent the insertion of a SEMS for an obstructing malignant lesion of the left-sided colon or rectum.

Results: In 55 patients, the stents were placed for palliation, whereas in 12 they were placed as a bridge to surgery. Stent placement was technically successful in 92.5% (n = 62), with a clinical success rate of 88% (n = 59). Two perforations that occurred during stent placement we retreated by an emergency Hartmann operation. In intention-to-treat by stent, the peri-interventional mortality was 6% (4/67). Stent migration was reported in 3 cases (5%), and stent obstruction occurred in 8 cases (13.5%). Of the nine patients with stents successfully placed as a bridge to surgery, all underwent elective single-stage operations with no death or anastomotic complication.

Conclusions: Stent insertion provided an effective outcome in patients with malignant colonic obstruction as a palliative and preoperative therapy.

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Colorectal Neoplasms / complications*
  • Colorectal Neoplasms / pathology
  • Emergency Treatment / methods
  • Equipment Design
  • Female
  • Follow-Up Studies
  • Humans
  • Intestinal Obstruction / etiology*
  • Intestinal Obstruction / pathology
  • Intestinal Obstruction / therapy*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Palliative Care / methods*
  • Quality of Life
  • Retrospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Stents*
  • Survival Rate
  • Treatment Outcome